Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Eugene Huffstutter

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Annals of Internal Medicine|February 7, 2018
MACRA: Big Fix or Big Problem?J Eugene Huffstutter
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|May 25, 2016
Overview of Auditing for the Busy RheumatologistJessica G Huffstutter, J Eugene Huffstutter
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|October 18, 2006
Treatment of resistant adult still disease with infliximab: a report of 2 casesJ Eugene Huffstutter, Charles W Sienknecht
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|January 8, 2008
Cutaneous mucormycosis complicating methotrexate, prednisone, and infliximab therapyHarsha Gadadhar, Stephen Hawkins, J Eugene Huffstutter, et al.
Arthritis Research & Therapy|January 27, 2021
Ixekizumab, with or without concomitant methotrexate, improves signs and symptoms of PsA: week 52 results from Spirit-P1 and Spirit-P2 studiesBernard Combe, Tsen-Fang Tsai, J Eugene Huffstutter, et al.
The Journal of Rheumatology|April 13, 2002
Open label study to assess infliximab safety and timing of onset of clinical benefit among patients with rheumatoid arthritisWilliam J Shergy, Reuben A Isern, David A Cooley, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Annals of Internal Medicine|February 7, 2018
MACRA: Big Fix or Big Problem?J Eugene Huffstutter
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|May 25, 2016
Overview of Auditing for the Busy RheumatologistJessica G Huffstutter, J Eugene Huffstutter
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|October 18, 2006
Treatment of resistant adult still disease with infliximab: a report of 2 casesJ Eugene Huffstutter, Charles W Sienknecht
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|January 8, 2008
Cutaneous mucormycosis complicating methotrexate, prednisone, and infliximab therapyHarsha Gadadhar, Stephen Hawkins, J Eugene Huffstutter, et al.
Arthritis Research & Therapy|January 27, 2021
Ixekizumab, with or without concomitant methotrexate, improves signs and symptoms of PsA: week 52 results from Spirit-P1 and Spirit-P2 studiesBernard Combe, Tsen-Fang Tsai, J Eugene Huffstutter, et al.
The Journal of Rheumatology|April 13, 2002
Open label study to assess infliximab safety and timing of onset of clinical benefit among patients with rheumatoid arthritisWilliam J Shergy, Reuben A Isern, David A Cooley, et al.
Pageof 1